Retapamulin
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Indicated for the topical treatment of impetigo due to S. aureus (MSSA) or S. pyogenes in patients >9 months old.
NON-FDA APPROVED USES
- In vitro activity against MRSA, but no clinical data.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Indicated for the topical treatment of impetigo due to S. aureus (MSSA) or S. pyogenes in patients >9 months old.
NON-FDA APPROVED USES
- In vitro activity against MRSA, but no clinical data.
There's more to see -- the rest of this entry is available only to subscribers.